BlackRock, Inc. 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
BLACKROCK INC BLK |
2,715,672 5.700% |
299,484 (+12.39%) |
Filing |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
BLACKROCK INC BLK |
2,416,188 5.500% |
2,416,188 (New Position) |
Filing |